Precigen (PGEN) Liabilities and Shareholders Equity (2016 - 2025)

Precigen (PGEN) has disclosed Liabilities and Shareholders Equity for 13 consecutive years, with $171.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity rose 105.17% to $171.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $547.2 million, a 23.66% increase, with the full-year FY2024 number at $145.3 million, down 3.82% from a year prior.
  • Liabilities and Shareholders Equity was $171.3 million for Q3 2025 at Precigen, up from $101.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $402.6 million in Q2 2021 to a low of $73.2 million in Q2 2024.
  • A 5-year average of $216.7 million and a median of $199.1 million in 2023 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: crashed 64.75% in 2024, then soared 105.17% in 2025.
  • Precigen's Liabilities and Shareholders Equity stood at $359.9 million in 2021, then plummeted by 39.98% to $216.0 million in 2022, then crashed by 30.07% to $151.0 million in 2023, then dropped by 3.82% to $145.3 million in 2024, then rose by 17.9% to $171.3 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Liabilities and Shareholders Equity are $171.3 million (Q3 2025), $101.9 million (Q2 2025), and $128.8 million (Q1 2025).